ARG1 and neoplasm: We treated KLN205 tumor-bearing C57BL6 mice after BCG injection with a commercially available Arg-1 inhibitor (ABH) at a dose of 200 μg i.p. every 2 days for a total of 12 times, and tumor growth rate was monitored over 22 days.